CERTAIN INFORMATION IDENTIFIED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.Advance Purchase Agreement • August 5th, 2021 • Novavax Inc • Biological products, (no disgnostic substances)
(1)Gavi Alliance, an independent non-profit foundation within the meaning of Articles 80 to 89 of the Swiss Civil Code with a registered office at Chemin du Pommier 40, 1218 Le Grand-Saconnex, Geneva, Switzerland (“Gavi”); and
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 5th, 2021 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment to Employment Agreement (this “Amendment”) amends the Employment Agreement between Novavax, Inc. (the “Company”) and [____________] (the “Executive”), dated as of [____________] (the “Employment Agreement”). This Amendment shall be effective as of [_______], 2021 (the “Effective Date”). All capitalized terms used in this Amendment shall have the meanings ascribed to them in the Employment Agreement unless otherwise expressly provided herein.
EMPLOYMENT AGREEMENTEmployment Agreement • August 5th, 2021 • Novavax Inc • Biological products, (no disgnostic substances) • Maryland
This Employment Agreement (this “Agreement”) between Novavax, Inc., (“Novavax” or the “Company”), a Delaware corporation having its principal office at 21 Firstfield Road, Gaithersburg, MD 20878, and Gregory Covino (“Executive”) and is effective as of April 13, 2021 (the “Effective Date”). As of the Effective Date, this Agreement amends and restates in its entirety the Employment Agreement between Novavax and Executive dated October 30, 2020.
